Skip to main content
. 2018 Apr 5;28(4):176–184. doi: 10.2188/jea.JE20160113

Table 2. Analysis of associated factors in men over 40 years old (n = 5,450).

Variables N (%)a (95% CI) Dizzinessb (95% CI) Univariable analysis Multivariable analysisd


P value OR (95% CI) P value OR (95% CI)
Demographic data
Age, years (5,450)c     0.00   0.00  
 40–49 37.99 (36.02–39.97) 10.17 (8.18–12.16)   1   1
 50–59 31.19 (29.56–32.83) 11.95 (9.89–14.00)   1.19 (0.91–1.57)   1.22 (0.90–1.64)
 60–69 17.73 (16.58–18.87) 18.96 (16.11–21.81)   2.07 (1.57–2.73)   2.11 (1.54–2.89)
 70–79 10.81 (9.94–11.69) 25.45 (22.11–28.89)   3.02 (2.31–3.96)   2.55 (1.82–3.57)
 >80 2.27 (1.87–2.67) 38.13 (29.59–46.68)   5.45 (3.57–8.31)   5.26 (2.90–9.55)
House income (5,374)     0.04   0.93  
 Lower (%) 18.14 (16.80–19.49) 23.28 (20.10–26.47)   1.44 (1.07–1.94)   0.99 (0.73–1.36)
 Lower-middle (%) 26.39 (24.73–28.06) 13.85 (11.511–16.19)   1.03 (0.79–1.35)   0.92 (0.68–1.23)
 Upper-middle (%) 26.98 (25.42–28.54) 12.19 (9.89–14.49)   1 (0.75–1.33)   0.94 (0.70–1.27)
 Upper (%) 28.48 (26.64–30.33) 11.87 (9.78–13.95)   1   1
Physical examination
Waist circumference (5,430)     0.71      
 <90 cm 72.21 (70.63–73.78) 14.34 (12.75–15.93)   1    
 ≥90 cm 27.79 (26.22–29.37) 15.11 (12.72–17.51)   1.04 (0.83–1.31)    
Serum TG level (5.035)     0.13      
 <150 mg/dL 54.30 (52.55–56.04) 13.73 (12.06–15.40)   1    
 ≥150 mg/dL 45.70 (43.96–47.45) 14.48 (12.43–16.52)   1.17 (0.96–1.44)    
Serum HDL level (5,066)     0.12      
 >40 mg/dL 67.33 (65.70–68.95) 13.92 (12.30–15.53)   1    
 ≤40 mg/dL 32.67 (31.05–34.30) 14.72 (12.59–16.84)   1.04 (0.84–1.23)    
 Vitamin D (5,450)     0.02 0.98 (0.96–0.99) 0.06 0.98 (0.97–1.00)
Otologic examination
TM perforation (No) 96.86 (96.26–97.46) 13.99 (12.61–15.37) 0.41 1    
 (5,009) (Yes) 3.14 (2.54–3.74) 19.42 (11.98–26.86)   1.22 (0.76–1.99)    
Cholesteatoma (No) 97.85 (97.33–98.36) 14.13 (12.74–15.53) 0.99 1    
 (5,009) (Yes) 2.15 (1.64–2.67) 15.36 (7.69–23.02)   1.00 (0.55–1.81)    
Otitis media with effusion (No) 99.30 (99.00–99.59) 14.10 (12.07–15.50) 0.55 1    
 (5,009) (Yes) 0.70 (0.41–1.00) 22.66 (6.41–38.91)   1.36 (0.50–3.72)    
Chronic otitis media (No) 95.13 (94.35–95.90) 14.00 (12.62–15.39) 0.70 1    
 (5,009) (Yes) 4.87 (4.10–5.64) 17.19 (11.53–22.85)   1.08 (0.73–1.61)    
Comorbidities
Hypertension (5,253)c     0.88      
 No 45.13 (43.38–46.88) 13.47 (11.60–15.34)   1    
 Yes 54.87 (53.12–56.62) 15.07 (13.26–16.88)   0.98 (0.80–1.21)    
DM (5,035)     0.46      
 No 76.13 (74.59–77.67) 13.43 (11.90–14.96)   1    
 Yes 23.87 (22.33–25.41) 16.12 (13.46–18.78)   1.11 (0.87–1.41)    
Cerebral stroke (5,268)     0.00   0.09  
 No 97.55 (97.11–97.99) 13.90 (12.52–15.28)   1   1
 Yes 2.45 (2.01–2.89) 31.51 (24.10–38.92)   1.85 (1.29–2.66)   1.41 (0.95–2.11)
Myocardial infarction (5,268)     0.43      
 No 96.33 (95.74–96.92) 14.07 (12.67–15.46)   1    
 Yes 3.67 (3.08–4.26) 21.31 (14.61–28.01)   1.20 (0.77–1.86)    
Chronic obstructive pulmonary disease (5,106)     0.75      
 No 99.07 (98.77–99.36) 14.33 (12.93–15.73)   1    
 Yes 0.93 (0.64–1.23) 20.65 (6.66–34.65)   1.15 (0.49–2.67)    
Arthritis (5,268)     0.00   0.05  
 No 91.12 (90.24–92.01) 13.28 (11.89–14.66)   1   1
 Yes 8.88 (7.99–9.76) 25.16 (20.63–29.69)   1.73 (1.32–2.26)   1.38 (1.00–1.92)
Depression (5,268)     0.00   0.00  
 No 91.38 (90.46–92.30) 13.16 (11.78–14.54)   1   1
 Yes 8.62 (7.70–9.54) 26.74 (21.42–32.06)   2.32 (1.73–3.10)   1.71 (1.24–2.36)
Functional status
Limited functional status due to visual acuity (5,265)   0.00   0.03  
 No limitation 89.35 (88.28–90.43) 12.82 (11.43–14.21)   1   1
 Limitation due to visual acuity 0.83 (0.52–1.13) 22.99 (10.63–35.34)   1.70 (0.88–3.26)   1.39 (0.69–2.80)
 Limitation but no due to visual acuity 9.82 (8.79–10.86) 27.24 (22.40–32.07)   2.09 (1.58–2.77)   1.56 (1.11–2.19)
Physical performance (5,265)     0.00   0.04  
 No difficulties in walking 86.87 (85.75–87.98) 12.08 (10.72–13.44)   1   1
 Partial difficulties in walking 12.61 (11.53–13.70) 28.08 (24.05–32.11)   2.12 (1.68–2.68)   1.45 (1.05–2.01)
 Bedridden 0.52 (0.30–0.74) 54.01 (32.80–75.22)   5.17 (1.91–14.00)   2.71 (0.81–9.11)
Activity of daily living (5,265)     0.00   0.96  
 No difficulties in ADL 91.53 (90.57–92.49) 12.79 (11.41–14.17)   1   1
 Partial difficulties in ADL 7.44 (6.57–8.30) 29.71 (24.31–35.12)   2.20 (1.64–2.97)   1.01 (0.69–1.49)
 Cannot do ADL 1.04 (0.71–1.36) 38.59 (23.63–53.56)   3.05 (1.68–5.55)   1.13 (0.48–2.66)
Health behavior
Smoking (5,266)     0.02   0.07  
 No 58.82 (57.14–60.50) 14.12 (12.54–15.69)   1   1
 Yes 41.18 (39.50–42.86) 14.49 (12.48–16.49)   1.25 (1.03–1.50)   1.2 (0.98–1.46)
Alcohol consumption (once a month) (5,248)     0.12      
 No 27.38 (25.85–28.91) 17.49 (15.01–19.97)   1    
 Yes 72.62 (71.09–74.15) 13.10 (11.59–14.61)   0.85 (0.69–1.05)    
Sleep hours (5,256)     0.44      
 ≤5 hr 13.30 (12.17–14.43) 18.20 (14.86–21.53)   1.20 (0.97–1.59)    
 ≤6 hr 27.76 (26.18–29.34) 13.46 (11.29–15.62)   1.03 (0.79–1.35)    
 ≤7 hr 29.43 (27.81–31.04) 13.02 (10.84–15.20)   1    
 ≤8 hr 22.22 (20.83–23.61) 13.44 (10.78–16.10)   0.93 (0.69–1.25)    
 ≥9 hr 7.30 (6.37–8.22) 17.89 (13.03–22.75)   1.19 (0.82–1.74)    
Perception of stress (5,266)     0.00   0.00  
 Very much 3.39 (2.79–3.98) 18.85 (12.16–25.54)   2.05 (1.25–3.35)   1.44 (0.85–2.43)
 Much 18.00 (16.69–19.30) 18.67 (15.63–21.70)   2.30 (1.65–3.21)   1.72 (1.21–2.44)
 Little 60.95 (59.40–62.50) 12.74 (11.04–14.44)   1.26 (0.96–1.65)   1.13 (0.85–1.49)
 None 17.67 (16.42–18.92) 14.18 (11.55–16.81)   1   1

ADL, activities of daily living; CI, confidence interval; DM, diabetes mellitus; HDL, high-density lipoprotein; OR, odds ratio; TG, triglycerides; TM, tympanic membrane.

aProportion of participants in the same group.

bPrevalence of dizziness in the subgroup.

cNumbers in parentheses: number of participants included in that particular factor.

dVariables with P-value ≤0.05 in univariable analysis were selected.

Adjusted for age.